SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response: 0.5

1. Name and Address of Reporting Person* Conway Robert G (Last) (First) (Middle) 101 POOR FARM ROAD (Street) PRINCETON NJ 08540 (City) (State) (Zip)	2. Date of Event Requiring Statement (Month/Day/Year) 10/03/2017	3. Issuer Name and Ticker or Trading Symbol AGILE THERAPEUTICS INC [ AGRX ]
		4. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner X Officer (give title below) Other (specify below) SVP Ent Planning & Info Mgt	5. If Amendment, Date of Original Filed (Month/Day/Year)
			6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (Right to Buy)	01/12/2009	01/11/2019	Common Stock	45	$285.71(1)	D
Employee Stock Option (Right to Buy)	12/09/2010	12/08/2020	Common Stock	4,149	$1.76(1)	D
Employee Stock Option (Right to Buy)	12/06/2012	12/05/2022	Common Stock	46,485	$4.38(1)	D
Employee Stock Option (Right to Buy)	02/19/2015	02/18/2025	Common Stock	30,000	$9.45(2)	D
Employee Stock Option (Right to Buy)	02/08/2016	02/07/2026	Common Stock	47,500	$5.93(3)	D
Employee Stock Option (Right to Buy)	01/25/2017	01/24/2027	Common Stock	38,000	$2.26(4)	D

Explanation of Responses:

1. This option is fully vested.

2. This option was granted on February 19, 2015. 25% of the shares subject to the stock option vested on February 19, 2016, and the remaining shares vest in 36 equal monthly installments over the following three years such that the option will be fully vested on February 19, 2019.

3. This option was granted on February 8, 2016. 25% of the shares subject to the stock option vested on February 8, 2017, and the remaining shares vest in 36 equal monthly installments over the following three years such that the option will be fully vested on February 8, 2020.

4. This option was granted on January 25, 2017. 25% of the shares subject to the stock option will vest on January 25, 2018, and the remaining shares vest in 36 equal monthly installments over the following three years such that the option will be fully vested on January 25, 2021.

Remarks:

Exhibit List Exhibit 24.1 - Power of Attorney.

	/s/ Scott Coiante, Attorney-in-Fact	10/12/2017
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.